UCELLO THERAPEUTICS
Ucello Therapeutics is engaged in development of allogeneic cell therapies using its proprietary CAR-T cell technology platform CBT-X20.
UCELLO THERAPEUTICS
Industry:
Biotechnology Medical Pharmaceutical
Founded:
2020-12-01
Address:
Chengdu, Sichuan, China
Country:
China
Website Url:
http://www.ucello.cn
Total Employee:
1+
Status:
Active
Contact:
+86 028 84729134
Email Addresses:
[email protected]
Total Funding:
60.29 M USD
Technology used in webpage:
SPF ASP.NET Alibaba
Similar Organizations
Alchemab Therapeutics
Alchemab Therapeutics is developing protective antibodies designed to keep people free of hard-to-treat diseases.
Aristea Therapeutics
Aristea Therapeutics is a developer of novel therapies created for autoimmune diseases.
Dyne Therapeutics
Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.
Obsidian Therapeutics
Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.
Tiburio Therapeutics
Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.
Investors List
InterChina Capital
InterChina Capital investment in Series A - Ucello Therapeutics
Penglai Capital
Penglai Capital investment in Series A - Ucello Therapeutics
Cowin Venture
Cowin Venture investment in Series A - Ucello Therapeutics
Guosheng Group
Guosheng Group investment in Series A - Ucello Therapeutics
Matrix Partners China
Matrix Partners China investment in Series A - Ucello Therapeutics
Juke Investment
Juke Investment investment in Series A - Ucello Therapeutics
Northern Light Venture Capital
Northern Light Venture Capital investment in Series A - Ucello Therapeutics
Elikon Venture
Elikon Venture investment in Series A - Ucello Therapeutics
Chengdu Tianfu International Bio-Town Investment & Development
Chengdu Tianfu International Bio-Town Investment & Development investment in Series A - Ucello Therapeutics
Cowin Venture
Cowin Venture investment in Series A - Ucello Therapeutics
More informations about "Ucello Therapeutics"
首页-企业官网
成都优赛诺生物科技有限公司成立于 2020 年，位于四川成都天府国际生物城，主营异体通用型 car-t 细胞治疗药物研发。. 优赛诺独有 cbt-x20tm 技术平台，通过 t 细胞的慢病毒感染、基因编 …See details»
关于我们-企业官网 - ucello.cn
成都优赛诺生物科技有限公司成立于2020年，位于四川成都天府国际生物城，主营异体通用型car-t细胞治疗药物研发与生产。See details»
Chengdu Ucello Therapeutics Co., Ltd - synapse.zhihuiya.com
了解Chengdu Ucello Therapeutics Co., Ltd (成都优赛诺生物科技有限公司)公司的药物管线，治疗领域，技术平台，以及它的1项临床试, 30篇新闻，药物:AT-I9 (Ucello Therapeutics)。 ...See details»
UCello - VentureRadar
" Ucello Therapeutics, established in December 2020 in Chengdu Tianfu International Bio-town, is a privately held biotechnology company focused on the development of allogeneic cell …See details»
Ucello Therapeutics - Crunchbase Company Profile
Ucello Therapeutics is engaged in development of allogeneic cell therapies using its proprietary CAR-T cell technology platform CBT-X20. Search Crunchbase. …See details»
Ucello Therapeutics - Org Chart, Teams, Culture & Jobs - The Org
Ucello Therapeutics is engaged in development of allogeneic cell therapies using its proprietary CAR-T cell technology platform CBT-X20. Industries. Biotechnology, Health Care +1. …See details»
Chengdu Ucello Therapeutics Co., Ltd - Drug pipelines, Patents ...
Explore Chengdu Ucello Therapeutics Co., Ltd with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, 1 news, Disease Domain:Neoplasms ...See details»
Ucello Therapeutics: Drug pipelines, Patents, Clinical trials - Synapse
Jun 28, 2023 Explore Ucello Therapeutics with its drug pipeline, therapeutic area, technology platform, , Technology Platform:CAR-T, Drug:ATI9 (Ucello Therapeutics).See details»
Ucello Therapeutics Company Profile - Office Locations ... - Craft
Ucello Technologies (also known as Chengdu Yousino Biotechnology, 优赛诺) is a company that develops and produces allogeneic universal CAR-T cell therapy drugs. Its CBT-X20TM …See details»
优赛诺生物 - 公司详情 - 产品&解决方案 - innoHere英诺嘿呀
优赛诺生物是一家专注于通用型细胞治疗产品开发及商业化的新创生物技术公司，于2020年12月在成都天府国际生物城成立。基于自主研发并且持续优化的通用型car-t 细胞技术平台cbt-x20， …See details»
Ucello Biotechnology Company Profile 2024: Valuation, Funding ...
Ucello Biotechnology General Information Description. Developer of allogeneic universal CAR-T cell therapeutic drugs designed to meet unmet clinical needs. The company's drugs leverage …See details»
Ucello Therapeutics - Overview, News & Similar companies
View Ucello Therapeutics (www.ucello.cn) location in Sichuan, China , revenue, industry and description. Find related and similar companies as well as employees by title and much more. …See details»
UCello | VentureRadar
Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and …See details»
优赛诺第一届年会盛典-企业官网 - ucello.cn
Jan 15, 2022 牛奔前程去, 虎 随好运来!告别难忘的2021,迎来全新 的 2022 。 2022年1月15日 ，成都优赛诺生物科技有 限公司 首届 年会在峨眉山山脚红珠山宾馆 举行。. 年会第一章：梦 …See details»
通用型细胞治疗研发公司优赛诺生物完成1.6亿元A轮融资
优赛诺生物(Ucello Therapeutics，下简称“优赛诺”)宣布，其近期已完成1.6亿元人民币的A轮融资，由经纬创投（Matrix Partners China）领投，凯风创投（Co-Win Ventures）、北极光创 …See details»
优赛诺生物 | 项目信息-36氪
优赛诺生物是一家专注于通用型细胞治疗产品开发及商业化的新创生物技术公司，于2020年12月在成都天府国际生物城成立。基于自主研发并且持续优化的通用型car-t 细胞技术平台cbt-x20， …See details»
优赛诺生物与深研生物达成战略合作，共建CGT产业链新格局
2022年9月22日，新一代通用型car-t治疗技术创领者成都优赛诺生物科技有限公司（以下简称“优赛诺生物”）与深圳市深研生物科技有限公司（以下简称“深研生物”）达成战略合作。See details»
Ucello - Company Profile - Tracxn
Ucello - Provider of allogeneic universal CAR-T cell therapy drugs. Ucello has 228 competitors.See details»
新闻资讯-企业官网 - ucello.cn
中国首个非病毒载体制备car-t细胞疗法 跻身2019年度“中国医药生物技术十大进展” 中新网上海新闻1月15日电(肖鑫 陈静)记者15日获悉，上海细胞治疗集团总裁、国家杰出青年科学基金获得者 …See details»
通用型细胞治疗研发公司优赛诺生物完成1.5亿元A+轮融资
四川省成都市双流区岐黄一路1000号11栋See details»